Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Mundipharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (114)
ARTG (99)
Australian public assessment report (AusPar) (9)
Prescription medicine registration (2)
Cancellation or suspension (1)

Date

2024 (16)
2023 (1)
2022 (62)
2021 (3)
2020 (28)
2019 (5)
2018 (7)
2017 (19)
2016 (11)
2015 (8)
2014 (8)
2013 (14)
2012 (1)
2011 (2)
2010 (7)
2005 (6)
2003 (3)
2001 (3)
2000 (7)
1999 (4)
1996 (1)
1995 (3)
1994 (1)
1993 (3)
1991 (2)

Search

Sponsor content

225 result(s) found, displaying 171 to 180

FLUTIFORM fluticasone propionate 250mcg / formoterol fumarate 10mcg pressurised metered dose inhaler (177875)

14 June 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FLUTIFORM fluticasone propionate 250mcg / formoterol fumarate 10mcg pressurised metered dose inhaler.
FLUTIFORM fluticasone propionate 50mcg / formoterol fumarate 5mcg pressurised metered dose inhaler (177869)

14 June 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FLUTIFORM fluticasone propionate 50mcg / formoterol fumarate 5mcg pressurised metered dose inhaler.
AusPAR: Buprenorphine

16 December 2016

Australian public assessment report (AusPar)

AusPAR: Buprenorphine
Dressing, hydrogel (Cancelled from the ARTG under s. 41GL(d) and the ARTG entry varied under s.41GO)

2 February 2016

Cancellation or suspension

Regulatory action due to The sponsor requested in writing the cancellation of these devices from the ARTG entry., effective 02/02/2016
SAFLUTAN tafluprost 15micrograms per/mL single dose eye drop ampoule (168803)

14 February 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SAFLUTAN tafluprost 15micrograms per/mL single dose eye drop ampoule.
LODOTRA prednisone 1 mg modified release tablet bottle Cancelled under s30(1)(c )

18 August 2015

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
LODOTRA prednisone 2 mg modified release tablet bottle Cancelled under s30(1)(c )

18 August 2015

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
LODOTRA prednisone 5 mg modified release tablet bottle Cancelled under s30(1)(c )

18 August 2015

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
TINASOLVE TINEA CREAM Cancelled under s30(1)(c) of the Act

15 June 2015

Cancellation by sponsor

Requested by Mundipharma Pty Ltd
RAPAID RASH RELIEF POWDER Cancelled under s30(1)(c) of the Act

15 June 2015

Cancellation by sponsor

Requested by Mundipharma Pty Ltd

Pages

First page
Previous page
…
Page 14
Page 15
Page 16
Page 17
Current page 18
Page 19
Page 20
Page 21
Page 22
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.